日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study

奇格列他扎治疗伴有高甘油三酯血症和胰岛素抵抗的MASLD：一项II期随机、双盲、安慰剂对照研究

期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000001475
Sun, Yameng; Wu, Cuisong; Xin, Guijie; Zhong, Bihui; Wu, Xiaofeng; Liu, Yali; Shi, Junping; Zhang, Qin; Zhao, Yingren; Gao, Yufeng; Xin, Yongning; Zhu, Yueyong; Wu, Lixian; Mao, Xiaorong; Du, Jian; Shang, Jia; Sun, Weiwei; Xu, Jie; Yu, Zujiang; Nan, Yuemin; Sheng, Huiping; Li, Yue; Rao, Huiying; Yu, Chaohui; Cao, Haixiang; Chen, Bo; Li, Zhibin; Wu, Xiaoning; Tong, Xiaofei; You, Hong
代谢
免疫/内分泌
发表日期：2026
文献求助 收藏

Activation of aryl hydrocarbon receptor alleviates cholestatic liver injury by inhibiting inflammation.

芳烃受体的激活可通过抑制炎症来减轻胆汁淤积性肝损伤。

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-026-02755-w
Han Qi, Wang Likai, Yan Xuzhen, Zhang Ning, Zhang Wen, Li Hong, Chen Wei, You Hong, Yang Aiting
肝损伤
炎症/感染
Immunology/Inflammation
炎症
发表日期：2026
文献求助 收藏

Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated Cirrhosis

不稳定代偿：乙型肝炎病毒相关失代偿性肝硬化患者的一种中间亚型

期刊:Alimentary Pharmacology & Therapeutics
影响因子:6.7
doi:10.1111/apt.70430
Xia, Shuai; He, Zhiying; Wu, Xiaoning; Hu, Zhongjie; Zhang, Chunqing; Hao, Yanqin; Yang, Yongfeng; Huang, Yan; Rao, Wei; Xu, Xiaoqian; Zhao, Xinyu; Zhou, Jialing; Sun, Yameng; Chen, Shuyan; Tang, Luqi; Ou, Xiaojuan; Zhao, Xinyan; Jia, Jidong; Wang, Bingqiong; You, Hong
微生物学
肝炎
肝硬化
发表日期：2026
文献求助 收藏

Chinese Guidelines for Clinical Diagnosis, Treatment, and Management of Cirrhosis (2025)

中国肝硬化临床诊断、治疗和管理指南（2025年版）

期刊:Journal of Clinical and Translational Hepatology
影响因子:4.2
doi:10.14218/JCTH.2025.00517
Xu, Xiaoyuan; Ding, Huiguo; You, Hong; Guan, Yujuan; Xu, Jinghang; Li, Wengang; Han, Ying; Wang, Yaping; Han, Yifan; Jia, Jidong; Wei, Lai; Duan, Zhongping; Nan, Yuemin; Zhuang, Hui; Hepatology, Chinese Society Of; Association, Chinese Medical
肝硬化
发表日期：2026
文献求助 收藏

The Extracellular Matrix in Liver Regeneration: Biological and Therapeutic Insights

肝脏再生中的细胞外基质：生物学和治疗学见解

期刊:Bioengineering-Basel
影响因子:3.8
doi:10.3390/bioengineering13030335
Ma, Haodong; Wu, Wenyue; Zhang, Wen; Li, Hong; Pan, Ziyan; Wang, Caihong; Gao, Ruoyu; Ji, Qiushuang; Chen, Zhi; You, Hong; Chen, Wei
细胞生物学
发表日期：2026
文献求助 收藏

Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis

直接胆红素在预测原发性胆汁性胆管炎患者的长期预后方面优于总胆红素。

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-026-04667-y
Chen, Sha; Li, Buer; Li, Shuxiang; Lv, Tingting; Xiao, Qin; Ma, Hong; Wang, Yu; Zhao, Xinyan; Ou, Xiaojuan; Kong, Yuanyuan; You, Hong; Jia, Jidong; Duan, Weijia
发表日期：2026
文献求助 收藏

Glucocorticoid Therapy for Recurrent In-Stent Restenosis: A Prospective Explorative Case Series

糖皮质激素治疗复发性支架内再狭窄：一项前瞻性探索性病例系列研究

期刊:JACC: Case Reports
影响因子:
doi:10.1016/j.jaccas.2026.107397
Yu, Miao; Yan, Hang-Yu; Wei, Zhi-Yao; Jiang, Yu; Song, Zhi-Feng; You, Hong-Zhao; Yang, Wei-Xian; Qian, Hai-Yan
免疫/内分泌
发表日期：2026
文献求助 收藏

Burden of liver cancer and underlying etiologies in China from 1990 to 2021: A systematic analysis from the Global Burden of Disease Study 2021

1990年至2021年中国肝癌负担及其潜在病因：2021年全球疾病负担研究的系统分析

期刊:Chinese Medical Journal
影响因子:
doi:10.1097/CM9.0000000000003828
Li, Menglong; He, Huiming; Zhao, Xinyu; Guan, Mengying; Khattab, Nourhan M; Elshishiney, Galal; You, Hong; Hu, Yifei
肿瘤
肝癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)

卡维地洛用于预防临床显著门静脉高压患者发生肝硬化失代偿，采用新的非侵入性模型进行分层（CHESS2306）

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2024.0198
Liu, Chuan; You, Hong; Zeng, Qing-Lei; Wong, Yu Jun; Wang, Bingqiong; Grgurevic, Ivica; Liu, Chenghai; Yim, Hyung Joon; Gou, Wei; Dong, Bingtian; Ju, Shenghong; Guo, Yanan; Yu, Qian; Hirooka, Masashi; Enomoto, Hirayuki; Hanafy, Amr Shaaban; Cao, Zhujun; Dong, Xiemin; Lv, Jing; Kim, Tae Hyung; Koizumi, Yohei; Hiasa, Yoichi; Nishimura, Takashi; Iijima, Hiroko; Xu, Chuanjun; Dai, Erhei; Lan, Xiaoling; Lai, Changxiang; Liu, Shirong; Wang, Fang; Guo, Ying; Lv, Jiaojian; Zhang, Liting; Wang, Yuqing; Xie, Qing; Shao, Chuxiao; Liu, Zhensheng; Ravaioli, Federico; Colecchia, Antonio; Li, Jie; Teng, Gao-Jun; Qi, Xiaolong
肝硬化
发表日期：2025
文献求助 收藏

Correspondence to editorial on "Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)"

致编辑的信函，主题为“卡维地洛预防临床显著门静脉高压患者肝硬化失代偿，采用新的非侵入性模型（CHESS2306）进行分层”

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2024.0723
Liu, Chuan; Yang, Ling; You, Hong; Teng, Gao-Jun; Qi, Xiaolong
肝硬化
发表日期：2025
文献求助 收藏